Explore Our Network

Explore MTEC's network of innovators, investors, and research organizations—along with patents and funding opportunities—advancing medical technologies for military and civilian health.

Showing 5 Patents
CD47 targeted therapies for the treatment of infectious disease

26-09-2017 • US-9771428-B2

WEISKOPF, KIPP ANDREW • HASENKRUG, KIM J. • STODDART, CHERYL A. • MCCUNE, JOSEPH M. • WEISSMAN, IRVING L.

University of California San Diego UCSD • Leland Stanford Junior University • US Department of Health and Human Services

CD47 targeted therapies for the treatment of infectious disease

10-10-2023 • US-11780931-B2

WEISKOPF, KIPP ANDREW • HASENKRUG, KIM J. • STODDART, CHERYL A. • MCCUNE, JOSEPH MCCRARY • WEISSMAN, IRVING L.

University of California San Diego UCSD • Leland Stanford Junior University • US Department of Health and Human Services

CD47 targeted therapies for the treatment of infectious disease

25-01-2022 • US-11230607-B2

WEISKOPF, KIPP ANDREW • HASENKRUG, KIM J. • STODDART, CHERYL A. • MCCUNE, JOSEPH MCCRARY • WEISSMAN, IRVING L.

University of California San Diego UCSD • Leland Stanford Junior University • US Department of Health and Human Services

CD47 targeted therapies for the treatment of infectious disease

28-07-2020 • US-10723803-B2

WEISKOPF, KIPP ANDREW • HASENKRUG, KIM J. • STODDART, CHERYL A. • MCCUNE, JOSEPH MCCRARY • WEISSMAN, IRVING L.

University of California San Diego UCSD • Leland Stanford Junior University • US Department of Health and Human Services

CD47 targeted therapies for the treatment of infectious disease

22-01-2019 • US-10184004-B2

WEISKOPF, KIPP ANDREW • HASENKRUG, KIM J. • STODDART, CHERYL A. • MCCUNE, JOSEPH MCCRARY • WEISSMAN, IRVING L.

University of California San Diego UCSD • Leland Stanford Junior University • US Department of Health and Human Services

Owner
Inventors
Assignee
Patent Type
Publication Year

JOIN OUR MAILING LIST

Stay Connected with MTEC

Keep up with active and upcoming solicitations, MTEC news and other valuable information.